No HELLP at all: Post-partum atypical hemolytic uremic syndrome treated with Eculizumab: A case report

Atypical hemolytic uremic syndrome (aHUS) is a rare condition among thrombotic microangiopathies (TMA). Pregnancy known precipitating factor of complement mediated TMA. The occurrence microangiopathic anemia, thrombocytopenia and acute kidney injury presents diagnostic therapeutic challenges. Diverse causes include hemolysis, elevated liver enzymes, low platelets (HELLP syndrome) in pregnant women. In pregnancy or postpartum, the aHUS critical complication requiring urgent diagnosis treatment. considered to be result underlying condition, with understanding that therapy focused on condition. Five documented cases pregnancy-associated treated Eculizumab have been reported, making extremely rare. We present case woman HELLP induced aHUS. patient presented evidence dysregulation system renal insufficiency. Since initiation Eculizumab, C5 inhibitor, development insufficiency diminished became dialysis independent.